Clinical Trial Update: Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Ivonescimab in combination with Gemcitabine and Nab-paclitaxel (GnP) and SBRT for metastatic pancreatic cancer; the study status is NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Ivonescimab (AK112/SMT112)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: West China Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING